Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Romanos Sklavenitis Pistofidis, M.D.

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma9202251961.110 Why?
HMGA1a Protein12021630.730 Why?
Waldenstrom Macroglobulinemia3202110770.510 Why?
Receptors, CXCR4120187290.440 Why?
RNA-Binding Proteins1202118910.400 Why?
Adaptor Proteins, Signal Transducing1202129090.350 Why?
Monoclonal Gammopathy of Undetermined Significance220201790.280 Why?
Gene Expression Regulation, Neoplastic1202186480.240 Why?
Neoplasm Recurrence, Local1202194190.200 Why?
Disease Models, Animal12021183490.190 Why?
Bone Marrow3202129350.190 Why?
Immunologic Factors2202215960.190 Why?
Clinical Trials, Phase II as Topic120226400.170 Why?
Disease Progression52022136680.160 Why?
Receptor, Interferon alpha-beta120181130.150 Why?
Plasma Cells120215990.140 Why?
Sequence Analysis, RNA2202120400.130 Why?
Mice, SCID1202126270.130 Why?
Stromal Cells1202113370.130 Why?
Mutation22019302370.120 Why?
Clone Cells1201816700.120 Why?
Cell Adhesion1202130970.120 Why?
Cell Proliferation22021104780.110 Why?
Tumor Cells, Cultured1202161240.110 Why?
Neoplasms, Experimental1201812300.100 Why?
Chromosome Aberrations1201817780.100 Why?
Tumor Microenvironment2202139480.090 Why?
Neoplasms, Second Primary1201810610.090 Why?
Antibodies, Viral1202132140.090 Why?
Base Sequence12021124220.080 Why?
Immunoglobulin G1202145680.080 Why?
Survival Rate22021128400.080 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1201815600.080 Why?
Cell Movement1202152130.080 Why?
Immune Tolerance1201823230.080 Why?
Decision Support Techniques1201920080.080 Why?
High-Throughput Nucleotide Sequencing1202036700.070 Why?
Asymptomatic Diseases220215900.070 Why?
Immunotherapy1202247540.070 Why?
Neoplasm Proteins1201836040.060 Why?
Prognosis32021300090.060 Why?
Apoptosis1202195270.060 Why?
T-Lymphocytes, Regulatory1201831150.060 Why?
Genomics1202059260.060 Why?
Humans1220227681710.050 Why?
Follow-Up Studies32019393540.050 Why?
Immunologic Tests120211040.050 Why?
Hematopoietic Stem Cell Transplantation1201857170.040 Why?
Risk2202296130.040 Why?
Models, Immunological120215180.040 Why?
Mice32021820490.040 Why?
beta 2-Microglobulin120193300.040 Why?
Antibodies, Blocking120182500.040 Why?
Antibodies, Neoplasm120182830.030 Why?
Female620213971870.030 Why?
Immunocompromised Host120218630.030 Why?
Myeloid Differentiation Factor 88120195820.030 Why?
Animals320211692850.030 Why?
Immunoglobulin M1201915280.030 Why?
Risk Factors42022749440.030 Why?
Male520213647310.020 Why?
Transplantation, Homologous1201848340.020 Why?
Disease-Free Survival1201968470.020 Why?
Biopsy1201967920.020 Why?
Combined Modality Therapy1201885420.020 Why?
Boston1201993740.020 Why?
Aged, 80 and over22020596260.010 Why?
Phenotype12022167260.010 Why?
Cell Line12018156020.010 Why?
Mice, Knockout12018144880.010 Why?
Predictive Value of Tests12019154530.010 Why?
Aged320201715020.010 Why?
Middle Aged320202234870.010 Why?
Adult320202236460.010 Why?
Risk Assessment12019243180.010 Why?
Time Factors12019402200.010 Why?
Prospective Studies12021549240.010 Why?
Signal Transduction12018236480.010 Why?
Sklavenitis Pistofidis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.